Literature DB >> 17479068

Births and ectopic pregnancies in a large cohort of women tested for Chlamydia trachomatis.

Inger Johanne Bakken1, Finn Egil Skjeldestad, Stian Lydersen, Svein Arne Nordbø.   

Abstract

BACKGROUND: Recent studies show divergent results concerning the risk of ectopic pregnancy following Chlamydia trachomatis (CT) infection. GOAL: Our goal was to investigate future reproductive health outcomes (births and ectopic pregnancies) among women tested for CT.
METHODS: Our cohort consisted of 20,762 women born during 1970-1984 who were tested for CT during 1990-2003. We linked CT data to data on ectopic pregnancies and births during 1990-2004. Cox regression with time-dependent covariates was used to assess the association between CT history and births/ectopic pregnancies adjusted for age at first test. Analyses with ectopic pregnancy as outcome were also adjusted for parity.
RESULTS: We observed 9.6 births per 100 person-years of observation among women with negative tests only and 10.2 per 100 person-years among women with at least 1 positive test (hazard ratio adjusted for age at first test, 1.07; 95% CI, 1.01-1.12). Ectopic pregnancy incidence rates were higher for women with positive test(s) compared with women with negative test only (0.24 vs. 0.13 per 100 person-years; hazard ratio adjusted for age at first test and parity, 1.82; 95% CI, 1.27-2.60). Among women with at least 1 registered pregnancy, the adjusted hazard ratio was 2.03; 95% CI, 1.28-3.22).
CONCLUSION: Although women diagnosed with CT were at higher risk for ectopic pregnancy than women with negative test results only, our study suggest that their fertility prospects were better than they would have been had CT screening not been implemented in this population. Opportunistic CT screening is an appropriate method for maintaining female reproductive health.

Entities:  

Mesh:

Year:  2007        PMID: 17479068     DOI: 10.1097/01.olq.0000261326.65503.f6

Source DB:  PubMed          Journal:  Sex Transm Dis        ISSN: 0148-5717            Impact factor:   2.830


  13 in total

Review 1.  Pathogenesis of genital tract disease due to Chlamydia trachomatis.

Authors:  Toni Darville; Thomas J Hiltke
Journal:  J Infect Dis       Date:  2010-06-15       Impact factor: 5.226

2.  The Reaction of Innate Lymphoid Cells in the Mouse Female Genital Tract to Chlamydial Infection.

Authors:  Svenja Barth; Susanne Kirschnek; Noemi Ortmann; Yakup Tanriver; Georg Häcker
Journal:  Infect Immun       Date:  2021-08-23       Impact factor: 3.441

3.  Association of anti-Chlamydia antibodies with ectopic pregnancy in Benin city, Nigeria: a case-control study.

Authors:  K Agholor; L Omo-Aghoja; F Okonofua
Journal:  Afr Health Sci       Date:  2013-06       Impact factor: 0.927

4.  Chlamydia trachomatis incidence and re-infection among young women--behavioural and microbiological characteristics.

Authors:  Jennifer Walker; Sepehr N Tabrizi; Christopher K Fairley; Marcus Y Chen; Catriona S Bradshaw; Jimmy Twin; Nicole Taylor; Basil Donovan; John M Kaldor; Kathleen McNamee; Eve Urban; Sandra Walker; Marian Currie; Hudson Birden; Francis Bowden; Jane Gunn; Marie Pirotta; Lyle Gurrin; Veerakathy Harindra; Suzanne M Garland; Jane S Hocking
Journal:  PLoS One       Date:  2012-05-25       Impact factor: 3.240

5.  The added value of chlamydia screening between 2008-2010 in reaching young people in addition to chlamydia testing in regular care; an observational study.

Authors:  Geneviève A F S van Liere; Nicole H T M Dukers-Muijrers; Jan E A M van Bergen; Hannelore M Götz; Frans Stals; Christian J P A Hoebe
Journal:  BMC Infect Dis       Date:  2014-11-18       Impact factor: 3.090

6.  Heterogeneity in risk of pelvic inflammatory diseases after chlamydia infection: a population-based study in Manitoba, Canada.

Authors:  Bethan Davies; Helen Ward; Stella Leung; Katy M E Turner; Geoff P Garnett; James F Blanchard; B Nancy Yu
Journal:  J Infect Dis       Date:  2014-12-01       Impact factor: 5.226

7.  The Netherlands Chlamydia cohort study (NECCST) protocol to assess the risk of late complications following Chlamydia trachomatis infection in women.

Authors:  B M Hoenderboom; A A M van Oeffelen; B H B van Benthem; J E A M van Bergen; N H T M Dukers-Muijrers; H M Götz; C J P A Hoebe; A A Hogewoning; F R M van der Klis; D van Baarle; J A Land; M A B van der Sande; M G van Veen; F de Vries; S A Morré; I V F van den Broek
Journal:  BMC Infect Dis       Date:  2017-04-11       Impact factor: 3.090

8.  Repeat infection with Chlamydia trachomatis: a prospective cohort study from an STI-clinic in Stockholm.

Authors:  Karin Edgardh; Sharon Kühlmann-Berenzon; Maria Grünewald; Maria Rotzen-Ostlund; Ivar Qvarnström; Jennie Everljung
Journal:  BMC Public Health       Date:  2009-06-22       Impact factor: 3.295

9.  Incidence of pelvic inflammatory disease in a large cohort of women tested for Chlamydia trachomatis: a historical follow-up study.

Authors:  Inger J Bakken; Sara Ghaderi
Journal:  BMC Infect Dis       Date:  2009-08-14       Impact factor: 3.090

10.  Risk of pelvic inflammatory disease following Chlamydia trachomatis infection: analysis of prospective studies with a multistate model.

Authors:  Malcolm J Price; A E Ades; Daniela De Angelis; Nicky J Welton; John Macleod; Kate Soldan; Ian Simms; Katy Turner; Paddy J Horner
Journal:  Am J Epidemiol       Date:  2013-06-27       Impact factor: 4.897

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.